In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter

Journal of Medicinal Chemistry

Volumn 39, Issue 1, 1996, Pages 191-196

  Lee, Lihsueh C ^a   Borght, Thierry Vander ^a   Sherman, Phillip S ^a   Frey, Kirk A ^a   Kilbourn, Michael R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,4,6,7 HEXAHYDRO 3 ISOBUTYL 2 OXO 11BH BENZO[A]QUINOLIZINE; BENZYLISOQUINOLINE DERIVATIVE; DIHYDROTETRABENAZINE; RADIOLIGAND; RADIOPHARMACEUTICAL AGENT; TETRABENAZINE; UNCLASSIFIED DRUG;

AMINE TRANSPORT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CORPUS STRIATUM; DRUG DESIGN; DRUG SYNTHESIS; FEMALE; HYPOTHALAMUS; INTRAVENOUS DRUG ADMINISTRATION; LIGAND BINDING; LIPOPHILICITY; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; POSITRON EMISSION TOMOGRAPHY; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNAPSE VESICLE;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BINDING, COMPETITIVE; BIOGENIC MONOAMINES; BIOLOGICAL TRANSPORT; BRAIN; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; NEUROPEPTIDES; RATS; SYNAPTIC VESICLES; TETRABENAZINE; VESICULAR BIOGENIC AMINE TRANSPORT PROTEINS; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 0030029369     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950117b     Document Type: Article

References (36)

1. Shuldiner, S. A molecular glimpse of vesicular monoamine transporters. J. Neurochem. 1994, 62, 2067-2078.
2. Erickson, J. D.; Eiden, L. E. Functional identification and molecular cloning of a human brain vesicle monoamine transporter. J. Neurochem. 1993, 61, 2314-2317.
3. Surratt, C.; Persico, A. M.; Yang, X.-D.; Edgar, S. R.; Bird, G. S.; Hawkins, A. L.; Griffin, C. A.; Li, X.; Jabs, E. W.; Uhl, G. R. A human synaptic vesicle monoamine transporter cDNA predicts posttranslational modifications, reveals chromosome 10 gene localization and identifies TaqI RFLPs. FEBS Lett. 1993, 318, 325-330.
4. Henry J.-P.; Scherman, D. Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles. Biochem. Pharmacol. 1989, 38, 2395-2404.
5. Scherman, D.; Desnos, C.; Darchen, F.; Pollak, P.; Javoy-Agid, F.; Agid, Y. Striatal dopamine deficiency in Parkinson's disease: role of aging. Ann. Neurol. 1989, 26, 551-557.
6. 11C]tetrabenazine to vesicular monoamine transporters in mouse brain. Life Sci. 1992, 51, 593-600.
7. 11C]tetrabenazine. Synapse 1993, 14, 128-131.
8. 11C]tetrabenazine and positron emission tomography. J. Neurochem. 1993, 60, 2315-2318.
9. Koeppe, R. A.; Frey, K. A.; Vander Borght, T. M.; Kilbourn, M. R.; Jewett, D. M.; Lee, L. C.; Kuhl, D. E. Kinetic evaluation of [C-11]dihydrotetrabenazine (DTBZ) by dynamic PET: a marker for the vesicular monoamine transporter. J. Cerebral Blood Flow Metab. 1995, 15, S651.
10. Vander Borght, T. M.; Kilbourn, M. R.; Koeppe, R. A.; DaSilva, J. N.; Carey, J. E.; Kuhl, D. E.; Frey, K. A. In vivo imaging of the brain vesicular monoamine transporter. J. Nucl. Med. 1995, in press.
11. Pletscher, A.; Brossi, A.; Gey, K. F. Benzoquinolizine derivatives: a new class of monoamine decreasing drugs with psychotropic action. Int. Rev. Neurobiol. 1962, 4, 275-306.
12. Scherman, D.; Gasnier, B.; Jaudon, P.; Henry, J.-P. Hydrophobicity of the tetrabenazine-binding site of the chromaffin granule monoamine transporter. Mol. Pharmacol. 1988, 33, 72-77.
13. 125I-iodovinyltetrabenazine to CNS vesicular monoamine transport sites. Synapse 1994, 18, 225-232.
14. Aranda, G.; Beaucourt, J. P.; Ponchant, M.; Isambert, M. F.; Henry, J. P. Synthesis and biological activity of iodinated and photosensitive derivatives of tetrabenazine. Eur. J. Med. Chem. 1990, 25, 369-374.
15. Pletscher, A.; Besendorf, H.; Gey, K. F. Depression of norepinephrine and 5-hydroxytryptamine in the brain by benzisoquinoline derivatives. Science 1959, 129, 844.
16. Cowan, D. O.; Mosher, H. S. Comparison of the reactions of Grignard reagents and dialkylmagnesium compounds in addition, reduction and emolization reactions. J. Org. Chem. 1962, 27, 1-5.
17. 13C chemical shifts. Chem. Pharm. Bull. 1978, 26, 1901-1907.
18. 13C chemical shifts. (2). Chem. Pharm. Bull. 1979, 27, 3144-3149.
19. Sugiura, M.; Takao, N.; Iwasa, K.; Sasaki, Y. Stereochemistry of quinolizidines. III. Carbon-13 magnetic resonance spectra of benzo[a]quinolizidines. Chem. Pharm. Bull. 1978, 26, 1168-1176.
20. Menendez, J. C.; Sollhuber, M. M. Stereochemistry of diasteromeric 9,10-dimethoxy-1,2,4,6,7,11b-hexahydrospiro[benzo[a]-quinizolidine]-2′, 4′-diones. Heterocycles 1987, 26, 3203-3209.
21. Uskokovic, M.; Bruderer, H.; von Planta, C.; Williams, T.; Brossi, A. The nuclear magnetic resonance spectra of the angular proton in benzo[a]- and indolo[a]quinolizidines. J. Am. Chem. Soc. 1964, 86, 3364-3367.
22. 13CH coupling constants in oxaziridines. J. Am. Chem. Soc. 1972, 94, 8501-8504.
23. 13C-H coupling constants in the stereochemical study of nitrogen bridgehead compounds. Heterocycles 1973, 1, 257-265.
24. Tourwe, D.; Van Binst, G.; Kametani, T. Conformational analysis of the dibenzo[a,g]quinolizidines by spectroscopic means. II. The use of high resolution 270 MHz proton magnetic resonance. Org. Magn. Reson. 1977, 9, 341-346.
25. Kilbourn, M. R.; Lee, L.; Vander Borght, T.; Jewett, D.; Frey, K. Binding of α-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific. Eur. J. Pharmacol. 1995, 278, 249-252.
26. Kilbourn, M. R.; Lee, L. C.; Jewett, D. M.; Vander Borght, T. M.; Koeppe, R. A.; Frey, K. A. In vitro and in vivo binding of α-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific. J. Cerebral Blood Flow Metab. 1995, 15, S650.
27. 3H]Methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity. Neuroscience 1995, 68, 955-962.
28. 11C]tetrabenazine as an in vivo radioligand for the vesicular monoamine transporter. Nucl. Med. Biol. 1994, 21, 151-156.
29. Kilbourn, M. R. PET radioligands for vesicular neurotransmitter transporters. Med. Chem. Res. 1994, 5, 113-126.
30. Katzenellenbogen, J. A. The Pharmacology of Steroid Radiopharmaceuticals: Specific and nonspecific Binding and Uptake Selectivity. In Radiopharmaceuticals: Chemistry and Pharmacology; Nunn, A. D., Ed.; Marcel Dekker: New York, 1992; pp 297-331.
31. Buckman, B. O.; Bonasera, T. A.; Kirschbaum, K. S.; Welch, M. J.; Katzenellenbogen, J. A. Fluorine-18-labeled progestin 16a, 17a-dioxalanes: development of high-affinity ligands for the progesterone receptor with high in vivo target site selectivity. J. Med. Chem. 1995, 38, 328-337.
32. Eckelman, W. C.; Grissom, M.; Conklin, J.; Rzeszotarski, W. J.; Gibson, R. E.; Francis, B. E.; Jagoda, E. M.; Eng, R.; Reba, R. C. In vivo competition studies with analogues of 3-quiniclidinyl benzilate. J. Pharm. Sci. 1984, 73, 529-534.
33. DaSilva, J. N.; Kilbourn, M. R.; Mangner, T. J. Synthesis of a [11C]methoxy derivative of α-dihydrotetrabenazine: a radioligand for studying the vesicular monoamine transporter. Appl. Radiat. Isot. 1993, 44, 1487-1489.
34. 3H]Dihydrotetrabenazine, a new in vitro monoaminergic probe for human brain. J. Neurochem. 1988, 50, 1131-1136.
35. 3H]muscimol binding in substantia nigra, entopeduncular nucleus, globus pallidus, and thalamus after striatal lesions as demonstrated by quantitative receptor autoradiography. J. Neurosci. 1983, 3, 1189-1198.
36. Munson, P. J.; Rodbard, D. Ligand: a versatile computerized approach for characterization of ligand-binding system. Anal. Biochem. 1980, 107, 220-239.